Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2021-05-25 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Notification of Major Holdings' and details changes in voting rights percentages held by T. Rowe Price Group, Inc. in Evotec SE, referencing specific sections of the German Securities Trading Act (WpHG). This content directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in ownership thresholds. The filing type code for this is MRQ.
2021-05-25 English
EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE
Earnings Release Classification · 100% confidence The document is titled "EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE". It contains detailed financial highlights for Q1 2021, including revenue figures, adjusted EBITDA, R&D expenses, and guidance confirmation for the full year 2021. The presence of detailed financial tables and the explicit mention of 'First quarter 2021' results strongly indicate this is a comprehensive report for a period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it also announces a conference call, the core content is the financial results themselves, making IR a more specific classification than ER (Earnings Release, which is usually just highlights) or CT (Call Transcript). Q1 2021
2021-05-11 English
Präsentation Q1 2021
Investor Presentation Classification · 100% confidence The document is a presentation titled 'Accelerating on the data-driven Autobahn to Cures' by Evotec. It contains financial highlights, operational updates, and strategic frameworks for Q1 2021. It includes charts, agenda items, and detailed financial tables (e.g., 'Condensed income statement Q1 2021'). As it is a slide deck used for investor communication regarding financial and operational performance, it is classified as an Investor Presentation. Q1 2021
2021-05-11 English
Q1 Mitteilung / Q1 Finanzbericht 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTALSMITTEILUNG Q1 2021' (Quarterly Statement Q1 2021) for Evotec SE. It contains detailed financial highlights, segment performance tables, operational updates, and a report on the financial position for the first quarter of 2021. It is a comprehensive interim report containing actual financial statements and analysis, not merely an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-11 German
Q1 statement / Q1 financial report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for Q1 2021, which provides comprehensive financial results, segment information, operational highlights, and management's analysis of the business performance. It contains actual financial statements and detailed data, distinguishing it from a mere announcement or a short summary. Therefore, it is classified as an Interim/Quarterly Report. Q1 2021
2021-05-11 English
Evotec SE: Bekanntmachung der Einberufung zur Hauptversammlung am 15.06.2021 in Hamburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Bekanntmachung der Einberufung zur Hauptversammlung am 15.06.2021' (Announcement of the Convocation to the Annual General Meeting on 15.06.2021). It details the date, time, and virtual nature of the 'ordentlichen (virtuellen) Hauptversammlung 2021' (Ordinary (Virtual) General Meeting 2021). The agenda items (Tagesordnung) cover standard AGM topics like approving financial statements, discharging management/supervisory boards, auditor appointment, and proposing changes to authorized capital, as well as electing a new Supervisory Board member. This content directly corresponds to the definition of AGM Information.
2021-05-06 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.